|
| Press Releases |
|
 |
|
| Tuesday, June 7, 2022 |
|
|
Novotech助力Endpoints ASCO 2022年專家組，加速中國腫瘤臨床試驗 |
| Novotech是亞太地區領先的生物技術臨床研究機構，近期入駐美國，助力Endpoints ASCO 2022年專家組，加速中國和美國臨床試驗進程。 more info >> |
|
|
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验 |
| Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，助力Endpoints ASCO 2022年专家组，加速中国和美国临床试验进程。 more info >> |
|
| Monday, June 6, 2022 |
|
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 "Accelerating clinical development in China and the US". more info >> |
|
| Friday, June 3, 2022 |
|
|
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 중국과 미국의 종양학 약물 전문가가 참여하는 2022년 프리-ASCO 중국 서밋의 전문가 패널들을 후원했다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其服務擴展到美國，在 2022 年 ASCO 前中國峰會上贊助了專家小組，匯集了中國和美國腫瘤藥物開發的領導者。 Pre-ASCO 系列在全球有超過 20,000 人觀看。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其服务扩展到美国，在 2022 年 ASCO 前中国峰会上赞助了专家小组，汇集了中国和美国肿瘤药物开发的领导者。 more info >> |
|
| Thursday, June 2, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US |
| Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US. more info >> |
|
| Thursday, May 12, 2022 |
|
|
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상시험수탁기관(CRO)인 노보텍(Novotech)은 '초기 단계 종양학 임상에 기반해 진행 여부 결정'이라는 제목의 2022년 프리-ASCO 중국 서밋(이하 '서밋')을 후원하게 된다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前夕：基於早期腫瘤學試驗的 Go/No Go 決策 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其 CRO 服務擴展到美國，很高興贊助 2022 年 ASCO 中國峰會前活動，題為：基於早期腫瘤試驗的 Go/No Go Decisions（“峰會”）。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ASCO 中国峰会前活动，题为：基于早期肿瘤试验的 Go/No Go Decisions（“峰会”）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
The Now Corporation (OTC:NWPN) In Conjunction With Subsidiary Green Rain Solar Inc., Launch a Visionary Video Showcasing Solar Energy Solutions
Jan 23, 2025 21:25 HKT/SGT
|
|
|
ZeroPath Corp. Launches Next-Generation Code Security Platform Powered by Artificial Intelligence
Jan 23, 2025 21:20 HKT/SGT
|
|
|
GTJAI Wins '2024 Best DCM House' and '2024 Best ESG DCM House' Awards
Jan 23, 2025 20:29 HKT/SGT
|
|
|
國泰君安國際榮獲「2024年度最佳承銷機構」及「2024年度最佳ESG承銷機構」兩項大獎
Jan 23, 2025 20:24 HKT/SGT
|
|
|
国泰君安国际荣获"2024年度最佳承销机构"及"2024年度最佳ESG承销机构"两项大奖
Jan 23, 2025 20:16 HKT/SGT
|
|
|
走好「最后一公里」联控多家AI大模型企业入选独角兽
Jan 23, 2025 20:08 HKT/SGT
|
|
|
U.S. Polo Assn. Celebrates the 2025 United States Winter Polo Season as Official Sponsor of the USPA National Polo Center (NPC)
Jan 23, 2025 20:00 HKT/SGT
|
|
|
走好「最後一公里」聯控多家AI大模型企業入選獨角獸
Jan 23, 2025 19:55 HKT/SGT
|
|
|
福壽園入圍達沃斯世界品牌峰會「2024世界創新品牌500強」
Jan 23, 2025 17:51 HKT/SGT
|
|
|
福寿园入围达沃斯世界品牌峰会"2024世界创新品牌500强"
Jan 23, 2025 17:13 HKT/SGT
|
|
|
Tay Guan Hin Receives First Ever 2025 AAMS Hall of Fame Visionary Award
Jan 23, 2025 13:40 HKT/SGT
|
|
|
The Now Corporation（OTC:NWPN）與旗下子公司 Green Rain Solar Inc. 推出展示太陽能解決方案的創新影片
Jan 23, 2025 13:00 HKT/SGT
|
|
|
Introducing the Sonim XP400: a 5g Smartphone Engineered for Demanding Days with Unmatched Durability, Now Available in EMEA and Australia
Jan 23, 2025 12:09 HKT/SGT
|
|
|
巴林勞工基金（Tamkeen）在達沃斯推出「巴林技能與性別平等加速器」
Jan 23, 2025 12:00 HKT/SGT
|
|
|
日本総合研究所と富士通が、三井住友銀行のシステムバージョンアップに生成AIを用いた共同実証で生産性向上を実現
Jan 23, 2025 10:15: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
